AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...

What Happens When the Nasal Septum is Misaligned ... evaluation by an ENT specialist is essential for determining the best treatment plan.

a chronic condition for which new and effective treatments are needed. Patients now have a non-surgical option available to them and an alternative to repeated exposure to oral corticosteroids.” It is ...

as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with nasal polyps (CRSwNP) in the adult population. This marks the third indication for an interleukin-5 (IL ...

They typically result from seasonal allergies or a bacterial infection requiring medical treatment ... such as nasal polyps. Also, it’s best to talk with a doctor if you have severe or ...

It is caused by physical blockages in the nasal passages, such as a deviated septum, nasal polyps, or enlarged adenoids. • The sounds /m/, /n/, and /ng/ sound like /b/, /d/, and /g/. Mixed rhinolalia: ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

Stuffy, sneezing, miserable: folks plagued by chronic sinusitis know the feeling all too well. Experts at University of Cincinnati Health say it's also an all-too-common affliction, affecting an ...

This treatment involves ... may be prescribed to reduce nasal inflammation, mucus production, and congestion, such as: Your healthcare provider will instruct you when and how often to use your ...

Johnson & Johnson's Spravato nasal spray has been FDA ... personalize the treatment paradigm for each individual” and determine the best way for them to manage the disease.